Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03494660 · ClinicalTrials.gov registry record

SCP Hip Outcomes Study

A clinical trial of Avascular Necrosis of Hip and Femoroacetabular Impingement, sponsored by Zimmer Biomet.

Active
Registry status
82
Enrollment target
6
Study locations

NCT03494660 is a study of Avascular Necrosis of Hip and Femoroacetabular Impingement that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 82 participants, below the 341-participant average among 4 other Avascular Necrosis of Hip trials with a reported enrollment target (76% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03494660, a study of Avascular Necrosis of Hip and Femoroacetabular Impingement, is active but no longer recruiting, sponsored by Zimmer Biomet.

ACTIVE NOT RECRUITING
Registry status
82 participants
Enrollment target
6
Study locations

Study Summary

Post-market clinical outcomes study to collect data on the short- and long-term outcomes for subjects who are undergoing or have undergone the Subchondroplasty® (SCP®) Procedure in the hip in a standard clinical setting. Outcomes to be assessed include medication usage, pain, function, activity levels and patient satisfaction.

Conditions Studied

Avascular Necrosis of Hip Femoroacetabular Impingement Bone Marrow Edema Dysplasia; Hip Subchondral Cysts Subchondral Bone Edema Insufficiency Fractures

Interventions

  • DEVICE Subchondroplasty Procedure with AccuFill

Study Locations (6)

Ohio

  • Cleveland Clinic Foundation - Cleveland
  • The Ohio State University - Columbus

California

  • Eisenhower Desert Orthopedic Center - Rancho Mirage

Florida

  • Andrews Research & Education Foundation - Gulf Breeze

Illinois

  • OrthoIllinois - Rockford

Kentucky

  • University of Kentucky Research Foundation - Lexington

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2018-03-27
Est. Completion 2025-12

Sponsor

Zimmer Biomet

115 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03494660

The ClinicalTrials.gov registry entry for NCT03494660 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 341-participant average among 4 other Avascular Necrosis of Hip trials with a reported enrollment target (76% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Avascular Necrosis of Hip appearing as the primary indexed condition, and to 1 intervention - of which Subchondroplasty Procedure with AccuFill is the first listed.

NCT03494660 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Ohio, California, Florida.

Frequently Asked Questions

What is clinical trial NCT03494660 about?

NCT03494660 is a clinical study titled "SCP Hip Outcomes Study". Post-market clinical outcomes study to collect data on the short- and long-term outcomes for subjects who are undergoing or have undergone the Subchondroplasty® (SCP®) Procedure in the hip in a standard clinical setting. Outcomes to be assessed include medication usage, pain, function, activity leve...

What is the current status of trial NCT03494660?

This trial is currently active not recruiting. The enrollment target is 82 participants. The study started on 2018-03-27. Estimated completion is 2025-12.

What conditions does trial NCT03494660 study?

This clinical trial studies the following conditions: Avascular Necrosis of Hip, Femoroacetabular Impingement, Bone Marrow Edema, Dysplasia; Hip, Subchondral Cysts.

What interventions are being tested in trial NCT03494660?

The interventions under investigation include: Subchondroplasty Procedure with AccuFill (DEVICE).

Who is sponsoring clinical trial NCT03494660?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03494660 being conducted?

This trial has 6 study locations across California, Florida, Illinois, Kentucky, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Avascular Necrosis of Hip

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Avascular Necrosis of Hip

All registered trials for this condition

Femoroacetabular Impingement

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.